NEXVOUND

Serial Number 99509700
641

Registration Progress

Application Filed
Nov 21, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action E-Mailed
Due: Apr 06, 2026 85 days

Trademark Image

NEXVOUND

Basic Information

Serial Number
99509700
Filing Date
November 21, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
641
Status Date
Jan 6, 2026
Application
Pending
Classes
005

Rights Holder

Eli Lilly and Company

03
Address
Lilly Corporate Center
Indianapolis, IN 46285

Ownership History

Eli Lilly and Company

Original Applicant
03
Indianapolis, IN

Legal Representation

Attorney
Bruce W. Longbottom

USPTO Deadlines

Next Deadline
85 days remaining
Non-Final Action E-Mailed
Due Date
April 06, 2026
Extension Available
Until July 06, 2026

Application History

8 events
Date Code Type Description Documents
Jan 6, 2026 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 6, 2026 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 6, 2026 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 22, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 17, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Dec 17, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 21, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Nov 21, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Covid-19 disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, weight management, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, peripheral arterial disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases.

Additional Information

Design Mark
The mark consists of the literal element "NEXVOUND" with the "N" capitalized and the remaining in lowercase with a graphic representation of a broken circular shape encompassing "VOU" in the color blue.
Color Claim
The color(s) blue is/are claimed as a feature of the mark.

Classification

International Classes
005